{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:18:08Z","timestamp":1793186288352,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-5497"],"award-info":[{"award-number":["A-5497"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-5497"],"award-info":[{"award-number":["A-5497"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","award":["BioDATEN"],"award-info":[{"award-number":["BioDATEN"]}],"id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deutsche Huntington Hilfe","award":["n.a."],"award-info":[{"award-number":["n.a."]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["NE 2372\/1-1"],"award-info":[{"award-number":["NE 2372\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"crossref","award":["n.a."],"award-info":[{"award-number":["n.a."]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["n.a."],"award-info":[{"award-number":["n.a."]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer's Society and Alzheimer's Research","award":["n.a."],"award-info":[{"award-number":["n.a."]}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200181\/Z\/15\/Z"],"award-info":[{"award-number":["200181\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS091161"],"award-info":[{"award-number":["NS091161"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS105709"],"award-info":[{"award-number":["NS105709"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS119471"],"award-info":[{"award-number":["NS119471"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A major challenge in neurodegenerative diseases concerns identifying biological disease signatures that track with disease progression or respond to an intervention. Several clinical trials in Huntington disease (HD), an inherited, progressive neurodegenerative disease, are currently ongoing. Therefore, we examine whether peripheral tissues can serve as a source of readily accessible biological signatures at the RNA and protein level in HD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We generate large, high-quality human datasets from skeletal muscle, skin and adipose tissue to probe molecular changes in human premanifest and early manifest HD patients\u2014those most likely involved in clinical trials. The analysis of the transcriptomics and proteomics data shows robust, stage-dependent dysregulation. Gene ontology analysis confirms the involvement of inflammation and energy metabolism in peripheral HD pathogenesis. Furthermore, we observe changes in the homeostasis of extracellular vesicles, where we find consistent changes of genes and proteins involved in this process. In-depth single nucleotide polymorphism data across the HTT gene are derived from the generated primary cell lines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our \u2018omics data document the involvement of inflammation, energy metabolism, and extracellular vesicle homeostasis. This demonstrates the potential to identify biological signatures from peripheral tissues in HD suitable as biomarkers in clinical trials. The generated data, complemented by the primary cell lines established from peripheral tissues, and a large panel of iPSC lines that can serve as human models of HD are a valuable and unique resource to advance the current understanding of molecular mechanisms driving HD pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13059-022-02752-5","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T04:03:54Z","timestamp":1662523434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues"],"prefix":"10.1186","volume":"23","author":[{"given":"Andreas","family":"Neueder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Kojer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Hering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Lavery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Birth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Hallitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Flower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-3536","authenticated-orcid":false,"given":"Michael","family":"Orth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"2752_CR1","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:15005.","journal-title":"Nat Rev Dis Primers"},{"key":"2752_CR2","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","volume":"14","author":"JB Carroll","year":"2015","unstructured":"Carroll JB, Bates GP, Steffan J, Saft C, Tabrizi SJ. Treating the whole body in Huntington's disease. Lancet Neurol. 2015;14:1135\u201342.","journal-title":"Lancet Neurol"},{"key":"2752_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci. 2005;6:919\u201330.","journal-title":"Nat Rev Neurosci"},{"key":"2752_CR4","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S. The Biology of Huntingtin. Neuron. 2016;89:910\u201326.","journal-title":"Neuron"},{"key":"2752_CR5","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1038\/s41467-020-18255-5","volume":"11","author":"AT Lu","year":"2020","unstructured":"Lu AT, Narayan P, Grant MJ, Langfelder P, Wang N, Kwak S, et al. DNA methylation study of Huntington\u2019s disease and motor progression in patients and in animal models. Nat Commun. 2020;11:4529.","journal-title":"Nat Commun"},{"key":"2752_CR6","doi-asserted-by":"crossref","unstructured":"Morozko EL, Smith-Geater C, Monteys AM, Pradhan S, Lim RG, Langfelder P, et al. PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington\u2019s disease. Proc Natl Acad Sci U S A. 2021;118:e2021836118","DOI":"10.1073\/pnas.2021836118"},{"key":"2752_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1092194","volume":"304","author":"JS Steffan","year":"2004","unstructured":"Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, et al. SUMO modification of Huntingtin and Huntington\u2019s disease pathology. Science. 2004;304:100\u20134.","journal-title":"Science"},{"key":"2752_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.neuron.2016.03.016","volume":"90","author":"J Ochaba","year":"2016","unstructured":"Ochaba J, Monteys AM, O'Rourke JG, Reidling JC, Steffan JS, Davidson BL, et al. PIAS1 regulates mutant huntingtin accumulation and Huntington\u2019s disease-associated phenotypes in vivo. Neuron. 2016;90:507\u201320.","journal-title":"Neuron"},{"key":"2752_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.celrep.2013.06.034","volume":"4","author":"JG O'Rourke","year":"2013","unstructured":"O'Rourke JG, Gareau JR, Ochaba J, Song W, Rasko T, Reverter D, et al. SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation. Cell Rep. 2013;4:362\u201375.","journal-title":"Cell Rep"},{"key":"2752_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1021\/acschemneuro.9b00509","volume":"11","author":"F Sedighi","year":"2020","unstructured":"Sedighi F, Adegbuyiro A, Legleiter J. SUMOylation prevents huntingtin fibrillization and localization onto lipid membranes. ACS Chem Neurosci. 2020;11:328\u201343.","journal-title":"ACS Chem Neurosci"},{"key":"2752_CR11","doi-asserted-by":"crossref","unstructured":"Ramirez-Jarquin UN, Sharma M, Zhou W, Shahani N, Subramaniam S. Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease. Proc Natl Acad Sci U S A. 2022;119:e2107187119.","DOI":"10.1073\/pnas.2107187119"},{"key":"2752_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13041-020-00657-7","volume":"13","author":"JM de Souza","year":"2020","unstructured":"de Souza JM, Abd-Elrahman KS, Ribeiro FM, Ferguson SSG. mGluR5 regulates REST\/NRSF signaling through N-cadherin\/beta-catenin complex in Huntington's disease. Mol Brain. 2020;13:118.","journal-title":"Mol Brain"},{"key":"2752_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","volume":"11","author":"R Johnson","year":"2009","unstructured":"Johnson R, Buckley NJ. Gene dysregulation in Huntington's disease: REST, microRNAs and beyond. NeuroMolecular Med. 2009;11:183\u201399.","journal-title":"NeuroMolecular Med"},{"key":"2752_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014311","volume":"5","author":"M Ravache","year":"2010","unstructured":"Ravache M, Weber C, Merienne K, Trottier Y. Transcriptional activation of REST by Sp1 in Huntington\u2019s disease models. PLoS One. 2010;5:e14311.","journal-title":"PLoS One"},{"key":"2752_CR15","doi-asserted-by":"publisher","first-page":"14275","DOI":"10.1038\/s41598-017-14290-3","volume":"7","author":"MK Bondulich","year":"2017","unstructured":"Bondulich MK, Jolinon N, Osborne GF, Smith EJ, Rattray I, Neueder A, et al. Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington\u2019s disease mice. Sci Rep. 2017;7:14275.","journal-title":"Sci Rep"},{"key":"2752_CR16","doi-asserted-by":"publisher","first-page":"16474","DOI":"10.1073\/pnas.1307680110","volume":"110","author":"J von Maltzahn","year":"2013","unstructured":"von Maltzahn J, Jones AE, Parks RJ, Rudnicki MA. Pax7 is critical for the normal function of satellite cells in adult skeletal muscle. Proc Natl Acad Sci U S A. 2013;110:16474\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2752_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005562","volume":"13","author":"T Suomi","year":"2017","unstructured":"Suomi T, Seyednasrollah F, Jaakkola MK, Faux T, Elo LL. ROTS: an R package for reproducibility-optimized statistical testing. PLoS Comput Biol. 2017;13:e1005562.","journal-title":"PLoS Comput Biol"},{"key":"2752_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.gendis.2019.12.001","volume":"8","author":"Q Yuan","year":"2021","unstructured":"Yuan Q, Li XD, Zhang SM, Wang HW, Wang YL. Extracellular vesicles in neurodegenerative diseases: insights and new perspectives. Genes Dis. 2021;8:124\u201332.","journal-title":"Genes Dis"},{"key":"2752_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77\u20139.","journal-title":"Nature"},{"key":"2752_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng0997-65","volume":"17","author":"G David","year":"1997","unstructured":"David G, Abbas N, Stevanin G, Durr A, Yvert G, Cancel G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997;17:65\u201370.","journal-title":"Nat Genet"},{"key":"2752_CR21","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1073\/pnas.1524575113","volume":"113","author":"G Wang","year":"2016","unstructured":"Wang G, Liu X, Gaertig MA, Li S, Li XJ. Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis. Proc Natl Acad Sci U S A. 2016;113:3359\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2752_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, et al. Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron. 2012;74:1031\u201344.","journal-title":"Neuron"},{"key":"2752_CR23","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1080\/13543784.2020.1804552","volume":"29","author":"RA Barker","year":"2020","unstructured":"Barker RA, Fujimaki M, Rogers P, Rubinsztein DC. Huntingtin-lowering strategies for Huntington\u2019s disease. Expert Opin Investig Drugs. 2020;29:1125\u201332.","journal-title":"Expert Opin Investig Drugs"},{"key":"2752_CR24","doi-asserted-by":"crossref","unstructured":"Marxreiter F, Stemick J, Kohl Z. Huntingtin lowering strategies. Int J Mol Sci. 2020;21:2146.","DOI":"10.3390\/ijms21062146"},{"key":"2752_CR25","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ejhg.2017.125","volume":"25","author":"MJ Chao","year":"2017","unstructured":"Chao MJ, Gillis T, Atwal RS, Mysore JS, Arjomand J, Harold D, et al. Haplotype-based stratification of Huntington\u2019s disease. Eur J Hum Genet. 2017;25:1202\u20139.","journal-title":"Eur J Hum Genet"},{"key":"2752_CR26","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s10038-019-0639-8","volume":"64","author":"KH Kim","year":"2019","unstructured":"Kim KH, Abu Elneel K, Shin JW, Keum JW, Seong D, Kwak S, et al. Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA. J Hum Genet. 2019;64:995\u20131004.","journal-title":"J Hum Genet"},{"key":"2752_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ajhg.2015.07.017","volume":"97","author":"JM Lee","year":"2015","unstructured":"Lee JM, Kim KH, Shin A, Chao MJ, Abu Elneel K, Gillis T, et al. Sequence-level analysis of the major European Huntington disease haplotype. Am J Hum Genet. 2015;97:435\u201344.","journal-title":"Am J Hum Genet"},{"key":"2752_CR28","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.18632\/aging.101005","volume":"8","author":"S Horvath","year":"2016","unstructured":"Horvath S, Langfelder P, Kwak S, Aaronson J, Rosinski J, Vogt TF, et al. Huntington\u2019s disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels. Aging (Albany NY). 2016;8:1485\u2013512.","journal-title":"Aging (Albany NY)"},{"key":"2752_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2183\/pjab.85.348","volume":"85","author":"N Fusaki","year":"2009","unstructured":"Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:348\u201362.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2752_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cr.2019.01.001","volume":"8","author":"S Yan","year":"2019","unstructured":"Yan S, Li S, Li XJ. Use of large animal models to investigate Huntington\u2019s diseases. Cell Regen. 2019;8:9\u201311.","journal-title":"Cell Regen"},{"key":"2752_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/cpns.47","volume":"83","author":"C Rangel-Barajas","year":"2018","unstructured":"Rangel-Barajas C, Rebec GV. Overview of Huntington\u2019s disease models: neuropathological, molecular, and behavioral differences. Curr Protoc Neurosci. 2018;83:e47.","journal-title":"Curr Protoc Neurosci"},{"key":"2752_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2217\/nmt-2019-0033","volume":"10","author":"A Neueder","year":"2020","unstructured":"Neueder A, Orth M. Mitochondrial biology and the identification of biomarkers of Huntington\u2019s disease. Neurodegener Dis Manag. 2020;10:243\u201355.","journal-title":"Neurodegener Dis Manag"},{"key":"2752_CR33","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, et al. Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet. 2006;15:965\u201377.","journal-title":"Hum Mol Genet"},{"key":"2752_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141298","volume":"10","author":"AT Labadorf","year":"2015","unstructured":"Labadorf AT, Myers RH. Evidence of extensive alternative splicing in post mortem human brain HTT transcription by mRNA sequencing. PLoS One. 2015;10:e0141298.","journal-title":"PLoS One"},{"key":"2752_CR35","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s11064-020-02993-5","volume":"45","author":"S Wojtowicz","year":"2020","unstructured":"Wojtowicz S, Strosznajder AK, Jezyna M, Strosznajder JB. The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer\u2019s disease and other neurodegenerative disorders. Neurochem Res. 2020;45:972\u201388.","journal-title":"Neurochem Res"},{"key":"2752_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-019-00500-6","volume":"35","author":"MA Altinoz","year":"2020","unstructured":"Altinoz MA, Ozpinar A, Ozpinar A, Hacker E. Erucic acid, a nutritional PPARdelta-ligand may influence Huntington\u2019s disease pathogenesis. Metab Brain Dis. 2020;35:1\u20139.","journal-title":"Metab Brain Dis"},{"key":"2752_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.4003","volume":"22","author":"AS Dickey","year":"2016","unstructured":"Dickey AS, Pineda VV, Tsunemi T, Liu PP, Miranda HC, Gilmore-Hall SK, et al. PPAR-delta is repressed in Huntington\u2019s disease, is required for normal neuronal function and can be targeted therapeutically. Nat Med. 2016;22:37\u201345.","journal-title":"Nat Med"},{"key":"2752_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","volume":"100","author":"JC Corona","year":"2016","unstructured":"Corona JC, Duchen MR. PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic Biol Med. 2016;100:153\u201363.","journal-title":"Free Radic Biol Med"},{"key":"2752_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.nbd.2011.08.016","volume":"45","author":"MC Chiang","year":"2012","unstructured":"Chiang MC, Chern Y, Huang RN. PPARgamma rescue of the mitochondrial dysfunction in Huntington\u2019s disease. Neurobiol Dis. 2012;45:322\u20138.","journal-title":"Neurobiol Dis"},{"key":"2752_CR40","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jnc.12190","volume":"125","author":"J Jin","year":"2013","unstructured":"Jin J, Albertz J, Guo Z, Peng Q, Rudow G, Troncoso JC, et al. Neuroprotective effects of PPAR-gamma agonist rosiglitazone in N171-82Q mouse model of Huntington\u2019s disease. J Neurochem. 2013;125:410\u20139.","journal-title":"J Neurochem"},{"key":"2752_CR41","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"C UniProt","year":"2021","unstructured":"UniProt C. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480\u20139.","journal-title":"Nucleic Acids Res"},{"key":"2752_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/BSR20100112","volume":"31","author":"M Fukuda","year":"2011","unstructured":"Fukuda M. TBC proteins: GAPs for mammalian small GTPase Rab? Biosci Rep. 2011;31:159\u201368.","journal-title":"Biosci Rep"},{"key":"2752_CR43","doi-asserted-by":"publisher","first-page":"4186308","DOI":"10.1155\/2020\/4186308","volume":"2020","author":"W Yuan","year":"2020","unstructured":"Yuan W, Song C. The emerging role of Rab5 in membrane receptor trafficking and signaling pathways. Biochem Res Int. 2020;2020:4186308.","journal-title":"Biochem Res Int"},{"key":"2752_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1083\/jcb.200509091","volume":"172","author":"A Pal","year":"2006","unstructured":"Pal A, Severin F, Lommer B, Shevchenko A, Zerial M. Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington\u2019s disease. J Cell Biol. 2006;172:605\u201318.","journal-title":"J Cell Biol"},{"key":"2752_CR45","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.1523\/JNEUROSCI.20-19-07268.2000","volume":"20","author":"KB Kegel","year":"2000","unstructured":"Kegel KB, Kim M, Sapp E, McIntyre C, Castano JG, Aronin N, et al. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci. 2000;20:7268\u201378.","journal-title":"J Neurosci"},{"key":"2752_CR46","doi-asserted-by":"publisher","first-page":"9000","DOI":"10.1523\/JNEUROSCI.0118-17.2017","volume":"37","author":"K Trajkovic","year":"2017","unstructured":"Trajkovic K, Jeong H, Krainc D. Mutant huntingtin is secreted via a late endosomal\/lysosomal unconventional secretory pathway. J Neurosci. 2017;37:9000\u201312.","journal-title":"J Neurosci"},{"key":"2752_CR47","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3389\/fnins.2019.01347","volume":"13","author":"PM Mathews","year":"2019","unstructured":"Mathews PM, Levy E. Exosome production is key to neuronal endosomal pathway integrity in neurodegenerative diseases. Front Neurosci. 2019;13:1347.","journal-title":"Front Neurosci"},{"key":"2752_CR48","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/1873-3468.14074","volume":"595","author":"LR Lizarraga-Valderrama","year":"2021","unstructured":"Lizarraga-Valderrama LR, Sheridan GK. Extracellular vesicles and intercellular communication in the central nervous system. FEBS Lett. 2021;595:1391\u2013410.","journal-title":"FEBS Lett"},{"key":"2752_CR49","volume":"11","author":"AG Yates","year":"2022","unstructured":"Yates AG, Pink RC, Erdbrugger U, Siljander PR, Dellar ER, Pantazi P, et al. In sickness and in health: the functional role of extracellular vesicles in physiology and pathology in vivo: Part II: Pathology: Part II: Pathology. J Extracell Vesicles. 2022;11:e12190.","journal-title":"J Extracell Vesicles"},{"key":"2752_CR50","doi-asserted-by":"crossref","unstructured":"Sanchez II, Nguyen TB, England WE, Lim RG, Vu AQ, Miramontes R, et al. Huntington\u2019s disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization. J Clin Invest. 2021;131:e140723.","DOI":"10.1172\/JCI140723"},{"key":"2752_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mdc3.12388","volume":"4","author":"GB Landwehrmeyer","year":"2017","unstructured":"Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, Goncalves N, Anderson KE, Cardoso F, et al. Data analytics from enroll-HD, a global clinical research platform for Huntington\u2019s disease. Mov Disord Clin Pract. 2017;4:212\u201324.","journal-title":"Mov Disord Clin Pract"},{"key":"2752_CR52","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","volume":"101","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Ghosh R, Leavitt BR. Huntingtin lowering strategies for disease modification in Huntington\u2019s disease. Neuron. 2019;101:801.","journal-title":"Neuron"},{"key":"2752_CR53","doi-asserted-by":"crossref","unstructured":"Chang CY, Ting HC, Liu CA, Su HL, Chiou TW, Lin SZ, et al. Induced pluripotent stem cell (iPSC)-based neurodegenerative disease models for phenotype recapitulation and drug screening. Molecules. 2020;25:2000.","DOI":"10.3390\/molecules25082000"},{"key":"2752_CR54","doi-asserted-by":"crossref","unstructured":"Csobonyeiova M, Polak S, Danisovic L. Recent overview of the use of iPSCs Huntington\u2019s disease modeling and therapy. Int J Mol Sci. 2020;21:2239.","DOI":"10.3390\/ijms21062239"},{"key":"2752_CR55","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1002\/hbm.23332","volume":"37","author":"M Orth","year":"2016","unstructured":"Orth M, Gregory S, Scahill RI, Mayer IS, Minkova L, Kloppel S, et al. Natural variation in sensory-motor white matter organization influences manifestations of Huntington\u2019s disease. Hum Brain Mapp. 2016;37:4615\u201328.","journal-title":"Hum Brain Mapp"},{"key":"2752_CR56","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009;8:791\u2013801.","journal-title":"Lancet Neurol"},{"key":"2752_CR57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group. Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord. 1996;11:136\u201342.","journal-title":"Mov Disord"},{"key":"2752_CR58","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol. 1997;41:689\u201392.","journal-title":"Ann Neurol"},{"key":"2752_CR59","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1136\/jnnp.2010.209668","volume":"82","author":"M Orth","year":"2011","unstructured":"Orth M. European Huntington's Disease N, Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB: Observing Huntington\u2019s disease: the European Huntington\u2019s Disease Network\u2019s REGISTRY. J Neurol Neurosurg Psychiatry. 2011;82:1409\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2752_CR60","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss A, Trager U, Wild EJ, Grueninger S, Farmer R, Landles C, et al. Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression. J Clin Invest. 2012;122:3731\u20136.","journal-title":"J Clin Invest"},{"key":"2752_CR61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.scr.2015.07.005","volume":"15","author":"M Demestre","year":"2015","unstructured":"Demestre M, Orth M, Fohr KJ, Achberger K, Ludolph AC, Liebau S, et al. Formation and characterisation of neuromuscular junctions between hiPSC derived motoneurons and myotubes. Stem Cell Res. 2015;15:328\u201336.","journal-title":"Stem Cell Res"},{"key":"2752_CR62","unstructured":"Andrews S: FastQC: a quality control tool for high throughput sequence data. 2010. http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc."},{"key":"2752_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"2752_CR64","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"2752_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1752-0509-6-63","volume":"6","author":"MC Oldham","year":"2012","unstructured":"Oldham MC, Langfelder P, Horvath S. Network methods for describing sample relationships in genomic datasets: application to Huntington\u2019s disease. BMC Syst Biol. 2012;6:63.","journal-title":"BMC Syst Biol"},{"key":"2752_CR66","doi-asserted-by":"crossref","unstructured":"Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2015;4:1521.","DOI":"10.12688\/f1000research.7563.1"},{"key":"2752_CR67","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2752_CR68","first-page":"275","volume":"18","author":"M Stephens","year":"2017","unstructured":"Stephens M. False discovery rates: a new deal. Biostatistics. 2017;18:275\u201394.","journal-title":"Biostatistics"},{"key":"2752_CR69","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.","journal-title":"BMC Bioinformatics"},{"key":"2752_CR70","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"},{"key":"2752_CR71","first-page":"356","volume":"3","author":"Z Zhang","year":"2015","unstructured":"Zhang Z. Missing data exploration: highlighting graphical presentation of missing pattern. Ann Transl Med. 2015;3:356.","journal-title":"Ann Transl Med"},{"key":"2752_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"2752_CR73","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1471-2105-12-322","volume":"12","author":"JA Miller","year":"2011","unstructured":"Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, Salomon DR, et al. Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics. 2011;12:322.","journal-title":"BMC Bioinformatics"},{"key":"2752_CR74","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu Z, Gu L, Eils R, Schlesner M, Brors B. circlize implements and enhances circular visualization in R. Bioinformatics. 2014;30:2811\u20132.","journal-title":"Bioinformatics"},{"key":"2752_CR75","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1093\/bioinformatics\/btv428","volume":"31","author":"T Galili","year":"2015","unstructured":"Galili T. dendextend: an R package for visualizing, adjusting and comparing trees of hierarchical clustering. Bioinformatics. 2015;31:3718\u201320.","journal-title":"Bioinformatics"},{"key":"2752_CR76","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan L, Fran\u00e7ois R, et al. Welcome to the Tidyverse. J Open Source Software. 2019;4:1686.","journal-title":"J Open Source Software"},{"key":"2752_CR77","unstructured":"Team RC: R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2022."},{"key":"2752_CR78","unstructured":"Neueder A: Bioinformatics scripts for the MTM-HD paper. Github. 2022. https:\/\/github.com\/ANeueder\/MTM-HD_data_paper."}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-022-02752-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-022-02752-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-022-02752-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T04:17:16Z","timestamp":1673583436000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/s13059-022-02752-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2752"],"URL":"https:\/\/doi.org\/10.1186\/s13059-022-02752-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.03.475821","asserted-by":"object"}]},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethics committees at Ulm University and University College London approved the study (Ulm: 265-12; London: 12\/LO\/1565), and written informed consent was obtained from each participant. All experimental methods comply with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.M.L serves in the scientific advisory board of GenEdit, Inc. A.N. acts as a consultant for Triplet Therapeutics, Inc. In the past 2\u00a0years, through the offices of UCL Consultants Ltd, a wholly owned subsidiary of University College London, S.J.T. has undertaken consultancy services for Alnylam Pharmaceuticals Inc., Atalanta Pharmaceuticals, F. Hoffmann-La Roche Ltd, Genentech, Guidepoint, Horama, Locanobio, LoQus23 Therapeutics Ltd, Novartis Pharma, PTC Therapeutics, Sanofi, Spark Therapeutics, Takeda Pharmaceuticals Ltd, Triplet Therapeutics, University College Irvine and Vertex Pharmaceuticals Incorporated. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}